loading
전일 마감가:
$18.40
열려 있는:
$18.02
하루 거래량:
6.77M
Relative Volume:
2.34
시가총액:
$13.18B
수익:
$956.00K
순이익/손실:
$-196.68M
주가수익비율:
-10.63
EPS:
-1.6811
순현금흐름:
$-113.02M
1주 성능:
+0.22%
1개월 성능:
-4.03%
6개월 성능:
+129.10%
1년 성능:
+636.91%
1일 변동 폭
Value
$17.71
$18.60
1주일 범위
Value
$16.83
$19.18
52주 변동 폭
Value
$2.10
$33.89

Summit Therapeutics Inc Stock (SMMT) Company Profile

Name
명칭
Summit Therapeutics Inc
Name
전화
305-203-2034
Name
주소
601 BRICKELL KEY DRIVE, MIAMI
Name
직원
105
Name
트위터
@summitplc
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
SMMT's Discussions on Twitter

SMMT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SMMT
Summit Therapeutics Inc
17.87 13.18B 956.00K -196.68M -113.02M -0.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Summit Therapeutics Inc Stock (SMMT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-11 개시 Wells Fargo Overweight
2024-12-06 개시 Jefferies Buy
2024-11-04 개시 JMP Securities Mkt Outperform
2024-09-27 다운그레이드 Citigroup Buy → Neutral
2024-08-12 개시 H.C. Wainwright Buy
2024-05-07 개시 Citigroup Buy
2024-03-26 개시 Stifel Buy
2018-06-28 다운그레이드 Janney Buy → Neutral
2018-05-02 개시 Janney Buy
2018-04-12 재확인 Needham Buy
2018-02-13 개시 BTIG Research Buy
2018-01-04 개시 SunTrust Buy
2017-12-01 재개 H.C. Wainwright Buy
2016-11-16 재확인 RBC Capital Mkts Outperform
2016-10-05 재확인 Needham Buy
2016-09-16 개시 H.C. Wainwright Buy
2015-03-30 개시 Needham Buy
2015-03-30 개시 Oppenheimer Outperform
모두보기

Summit Therapeutics Inc 주식(SMMT)의 최신 뉴스

pulisher
04:31 AM

Barclays PLC Lowers Stake in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

04:31 AM
pulisher
Dec 20, 2024

Why Did Summit Therapeutics Inc. (SMMT) Jump Yesterday? - Insider Monkey

Dec 20, 2024
pulisher
Dec 20, 2024

Why These 10 Stocks Jumped Yesterday - Insider Monkey

Dec 20, 2024
pulisher
Dec 20, 2024

Where Will Summit Therapeutics Be in 5 Years? - Yahoo Finance

Dec 20, 2024
pulisher
Dec 20, 2024

3 Stocks That Could Turn $1,000 into $5,000 by 2030 - The Motley Fool

Dec 20, 2024
pulisher
Dec 20, 2024

Wellington Management Group LLP Has $968,000 Position in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Dec 20, 2024
pulisher
Dec 19, 2024

Summit Therapeutics (NASDAQ:SMMT) Trading Up 6.8%Should You Buy? - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

(SMMT) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Dec 19, 2024
pulisher
Dec 18, 2024

Has Summit Therapeutics Stock Already Peaked? - AOL

Dec 18, 2024
pulisher
Dec 18, 2024

State Street Corp Sells 654,623 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Dec 18, 2024
pulisher
Dec 16, 2024

Here's Why Summit Therapeutics Stock Price Rose 6% on Friday - MSN

Dec 16, 2024
pulisher
Dec 15, 2024

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street - Yahoo! Voices

Dec 15, 2024
pulisher
Dec 14, 2024

Virtu Financial LLC Makes New Investment in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Dec 14, 2024
pulisher
Dec 13, 2024

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Dec 13, 2024
pulisher
Dec 12, 2024

Wells Fargo Initiates Coverage of Summit Therapeutics (SMMT) with Overweight Recommendation - MSN

Dec 12, 2024
pulisher
Dec 11, 2024

Summit Therapeutics (NASDAQ:SMMT) Earns Overweight Rating from Analysts at Wells Fargo & Company - MarketBeat

Dec 11, 2024
pulisher
Dec 07, 2024

Summit Therapeutics (NASDAQ:SMMT) Earns Buy Rating from Analysts at Jefferies Financial Group - MarketBeat

Dec 07, 2024
pulisher
Dec 07, 2024

Polar Asset Management Partners Inc. Takes Position in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Dec 07, 2024
pulisher
Dec 07, 2024

Why Summit Therapeutics Stock Rocketed 6% Higher on Friday - MSN

Dec 07, 2024
pulisher
Dec 06, 2024

Bank of Montreal Can Invests $2.04 Million in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

The Manufacturers Life Insurance Company Raises Stock Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Dec 06, 2024
pulisher
Dec 04, 2024

Warning: This Skyrocketing Stock Has a Hidden Risk - AOL

Dec 04, 2024
pulisher
Dec 04, 2024

Charles Schwab Investment Management Inc. Boosts Stake in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Rakovina Therapeutics Announces Presentation at the 13th Annual Tumour Models London Summit - Yahoo Finance

Dec 03, 2024
pulisher
Dec 03, 2024

Summit Therapeutics Inc. (NASDAQ:SMMT) Shares Acquired by Fmr LLC - MarketBeat

Dec 03, 2024
pulisher
Dec 02, 2024

Summit Therapeutics Stock Set To Soar By Mid-2025 On HARMONi Phase 3 Trial - Seeking Alpha

Dec 02, 2024
pulisher
Dec 02, 2024

Summit Therapeutics Inc. (NASDAQ:SMMT) Shares Acquired by Baker BROS. Advisors LP - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

Billionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% Higher - Yahoo Finance

Dec 02, 2024
pulisher
Dec 02, 2024

Cerity Partners LLC Invests $2.18 Million in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Dec 02, 2024
pulisher
Dec 01, 2024

2 Hot Biopharma Stocks to Buy and Hold for 5 Years - AOL

Dec 01, 2024
pulisher
Nov 30, 2024

Intech Investment Management LLC Invests $694,000 in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Nov 30, 2024
pulisher
Nov 29, 2024

Stock Market Movers Today • Top Gainers & Losers - Benzinga

Nov 29, 2024
pulisher
Nov 27, 2024

(SMMT) Investment Analysis and Advice - Stock Traders Daily

Nov 27, 2024
pulisher
Nov 26, 2024

Summit Therapeutics to Present at Upcoming Investor Conferences - BioSpace

Nov 26, 2024
pulisher
Nov 23, 2024

3 Monster Stocks in the Making - Yahoo Finance

Nov 23, 2024
pulisher
Nov 20, 2024

Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer? - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Summit Therapeutics (SMMT) Hurt Bronte Capital. Here’s Why - Insider Monkey

Nov 20, 2024
pulisher
Nov 18, 2024

Summit Therapeutics (NASDAQ:SMMT) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

(SMMT) Trading Report - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 14, 2024

Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics - Investor's Business Daily

Nov 14, 2024
pulisher
Nov 14, 2024

Merck signs up to $3.3 billion cancer drug deal with China-based LaNova - Reuters

Nov 14, 2024
pulisher
Nov 12, 2024

2 Stocks Up Over 700% in 2024 That Could Soar Even Further - AOL

Nov 12, 2024
pulisher
Nov 09, 2024

BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential - Benzinga

Nov 09, 2024
pulisher
Nov 09, 2024

Is Summit Therapeutics a Millionaire Maker? - AOL

Nov 09, 2024

Summit Therapeutics Inc (SMMT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Summit Therapeutics Inc 주식 (SMMT) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Zanganeh Mahkam
Chief Executive Officer
Mar 26 '24
Buy
3.75
30,000
112,500
30,000
Zanganeh Mahkam
Chief Executive Officer
Mar 27 '24
Buy
3.72
26,000
96,720
520,814
Dhingra Ankur
Chief Financial Officer
Mar 26 '24
Buy
3.75
100,000
375,000
354,958
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
자본화:     |  볼륨(24시간):